Bausch Health Companies (BHC) Net Margin (2009 - 2026)

Bausch Health Companies has disclosed Net Margin across 18 years of filings, most recently posting 56.7% for Q1 2026.

• Net Margin for Q1 2026 came in at 56.7%, down 5289.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 11.63% (down 1080.0% YoY), and the FY2025 annual result was 1.17%, up 192.0% from the prior year.
• Net Margin came in at 56.7% for Q1 2026 at Bausch Health Companies, down from 3.68% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 19.7% in Q3 2022 to a low of 56.7% in Q1 2026.
• The 5-year median for Net Margin is 3.58% (2024), against an average of 5.52%.
• Across the five-year window, Net Margin soared 3011 bps in 2022 and sank 5289 bps in 2026, its largest moves.
• Bausch Health Companies' Net Margin stood at 18.7% in 2022, then soared by 90 bps to 1.95% in 2023, then surged by 296 bps to 3.83% in 2024, then sank by 196 bps to 3.68% in 2025, then plunged by 1439 bps to 56.7% in 2026.
• The last three Net Margin figures came in at 56.7% (Q1 2026), 3.68% (Q4 2025), and 6.75% (Q3 2025), per Business Quant data.